首页> 美国卫生研究院文献>other >Heparanase Released From Mesenchymal Stem Cells Activates Integrin beta1/HIF-2alpha/Flk-1 Signaling and Promotes Endothelial Cell Migration and Angiogenesis
【2h】

Heparanase Released From Mesenchymal Stem Cells Activates Integrin beta1/HIF-2alpha/Flk-1 Signaling and Promotes Endothelial Cell Migration and Angiogenesis

机译:从间充质干细胞释放的乙酰肝素酶激活整联蛋白beta1 / HIF-2alpha / Flk-1信号传导并促进内皮细胞迁移和血管生成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heparanase plays important roles in tumor angiogenesis. Our previous study demonstrated that hypoxic preconditioning (HPC) enhanced the angiogenic and therapeutic effects of mesenchymal stem cells (MSCs), effects that were paralleled by enhanced heparanase expression. This study was designed to elucidate the role of heparanase in the improved therapeutic properties of HPC-MSCs and to explore underlying mechanisms using an ischemic rat hind limb model. MSCs transfected with heparanase (MSChpa) or empty vector (MSCnull) were delivered by intramuscular injections to ischemic hind limbs. Hind limbs that received MSChpa recovered blood flow more rapidly at 7 days and acquired higher capillary density at 14 days compared with MSCnull. Conditioned medium from MSChpa increased endothelial cell migration and promoted greater tube formation relative to that from the MSCnull groups. Vascular endothelial growth factor receptor 2 (VEGFR2, Flk-1) and its downstream signaling pathway (p38MAPK/HSP27) were significantly increased in human umbilical vein endothelial cells (HUVECs) after treatment with MSChpa conditioned medium. Each of these responses was decreased by cocultured with MSChpa-KD conditioned medium. MSChpa conditioned medium activated hypoxia-inducible factor-2α (HIF-2α) and increased in parallel the transcript level of Flk-1 as determined by chromatin immunoprecipitation-PCR and luciferase assays. Analyses of integrin expression revealed an important role for integrin β1 in the regulation of HIF-2α. All angiogenic effects of MSChpa conditioned medium were abolished by knockdown of integrin β1, HIF-2α, and Flk-1 in HUVECs with selective shRNAs. These findings identify heparanse as a key regulator of angiogenesis by MSCs. We propose a novel pathway wherein heparanse sequentially activates integrin β1, HIF-2α, Flk-1, and p38MAPK/HSP27 with corresponding enhancement of angiogenesis.
机译:乙酰肝素酶在肿瘤血管生成中起重要作用。我们以前的研究表明,低氧预处理(HPC)增强了间充质干细胞(MSCs)的血管生成和治疗作用,而这种作用与增强的乙酰肝素酶表达平行。这项研究旨在阐明乙酰肝素酶在改善HPC-MSC的治疗特性中的作用,并探索使用缺血大鼠后肢模型的潜在机制。将经乙酰肝素酶(MSC hpa )或空载体(MSC null )转染的MSC通过肌肉内注射递送至缺血性后肢。与MSC null 相比,接受MSC hpa 的后肢在第7天恢复的血流更快,在第14天获得更高的毛细血管密度。相对于MSC null 组的条件培养基,来自MSC hpa 的条件培养基增加了内皮细胞的迁移并促进了更大的管形成。 MSC 条件培养基处理后的人脐静脉内皮细胞(HUVEC)中,血管内皮生长因子受体2(VEGFR2,Flk-1)及其下游信号通路(p38MAPK / HSP27)显着增加。通过与MSC hpa-KD 条件培养基共培养,这些反应均降低。 MSC hpa 条件培养基激活了缺氧诱导因子2α(HIF-2α),并通过染色质免疫沉淀PCR和荧​​光素酶测定法平行地提高了Flk-1的转录水平。整联蛋白表达的分析揭示了整联蛋白β1在HIF-2α的调节中的重要作用。通过选择性shRNA敲除HUVECs中的整联蛋白β1,HIF-2α和Flk-1,消除了MSC hpa 条件培养基的所有血管生成作用。这些发现确定乙酰肝素是MSCs血管生成的关键调节剂。我们提出了一条新途径,其中肝素酶可依次激活整联蛋白β1,HIF-2α,Flk-1和p38MAPK / HSP27,并相应增强血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号